TIDMCPT

RNS Number : 9010R

Concepta PLC

02 July 2020

Concepta PLC

("Concepta" or the "Company")

Result of AGM

Concepta PLC (AIM: CPT), the innovative UK personalised healthcare company and developer of myLotus(R), the UK's most accurate home-use fertility tracking and pregnancy self-testing system, announces that at the Annual General Meeting ("AGM") held earlier today, all resolutions were duly passed.

Details of voting are provided below:

 
 Resolution            For     Against 
 Resolution 
  1            107,315,949      86,504 
              ------------  ---------- 
 Resolution 
  2            107,320,669      63,504 
              ------------  ---------- 
 Resolution 
  3            106,115,669   1,266,784 
              ------------  ---------- 
 Resolution 
  4            106,120,669   1,286,504 
              ------------  ---------- 
 Resolution 
  5            106,070,949   1,336,504 
              ------------  ---------- 
 Resolution 
  6            106,070,949   1,336,504 
              ------------  ---------- 
 Resolution 
  7            106,120,949   1,286,504 
              ------------  ---------- 
 Resolution 
  8            105,846,568   1,470,127 
              ------------  ---------- 
 Resolution 
  9            104,660,762   2,655,653 
              ------------  ---------- 
 
 
 Concepta plc                                                         www.conceptaplc.com 
 P enny McCormick , Chief Executive                                       via Walbrook PR 
  Officer 
 Maddy Kennedy, Chief Financial 
  Officer 
 
 SPARK Advisory Partners Limited                                 Tel: +44 (0)20 3368 3550 
  (NOMAD) 
 Neil Baldwin 
 
 Novum Securities (Broker)                                       Tel: +44 (0)20 7399 9400 
 Colin Rowbury 
 
 Walbrook PR Ltd (Media & Investor    Tel: +44 (0)20 7933 8780 or concepta@walbrookpr.com 
  Relations) 
 Paul McManus                                                     Mob: +44(0)7980 541 893

About Concepta PLC ( www.conceptaplc.com )

Concepta PLC is an AIM-quoted pioneering UK healthcare company that has developed a proprietary product, myLotus(R), targeted at the personalized mobile health market with a primary focus on hormone testing and increasing a woman's chances of naturally getting pregnant and to provide insight to unexplained infertility.

myLotus(R) is currently the only consumer product which allows both quantitative and qualitative home (self-test) test measurement of a woman's personal luteinizing hormone (LH) during ovulation and human chorionic gonadotropin (hCG) hormone level during pregnancy, facilitating higher conception rates and early diagnosis of fertility issues. The proposition of myLotus(R) is to empower women to better understand their hormone levels and menstrual cycle and help women conceive naturally by identifying their window of fertility and optimal time for conception.

The Company has received CE-mark certification for myLotus(R) and has launched its first product in the UK. The Company is preparing plans to roll-out across the core EU countries in 2020.

myLotus(R) is expected to be beneficial to users who have been unable to conceive after 6 months of trying. This highly motivated target group of women won't typically be offered medical intervention until after 12 months of unsuccessfully trying to conceive, with IVF not usually offered until after two years of trying to conceive. Research indicates couples start to take positive action ahead of this time typically with little medical support to help them do so.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RAGZLLFBBDLLBBF

(END) Dow Jones Newswires

July 02, 2020 10:24 ET (14:24 GMT)

Grafico Azioni Myhealthchecked (LSE:MHC)
Storico
Da Mar 2024 a Apr 2024 Clicca qui per i Grafici di Myhealthchecked
Grafico Azioni Myhealthchecked (LSE:MHC)
Storico
Da Apr 2023 a Apr 2024 Clicca qui per i Grafici di Myhealthchecked